More about

Anemia

News
December 05, 2023
2 min read
Save

Most US veterans with anemia, hematochezia do not undergo testing for early-onset CRC

Most US veterans with anemia, hematochezia do not undergo testing for early-onset CRC

Diagnostic test completion for early age-onset colorectal cancer is low among U.S. veterans presenting with iron-deficiency anemia or hematochezia, with women and Black and Hispanic veterans less likely to undergo follow-up testing.

News
November 14, 2023
4 min read
Save

Wish reviews progress in anemia management and potential for a new drug class

Wish reviews progress in anemia management and potential for a new drug class

Healio | Nephrology News & Issues interviewed Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical officer for dialysis at Indiana University Health in Indianapolis, about the role of anemia management in kidney care. Wish is also chair of the Editorial Advisory Board for Healio | Nephrology News & Issues.

News
November 14, 2023
6 min read
Save

New anemia drugs could change the steady state of kidney care

New anemia drugs could change the steady state of kidney care

During the last 3 decades, only one class of drugs – erythropoiesis-stimulating agents – has been available to treat anemia in patients with end-stage kidney disease. That has now changed.

News
November 13, 2023
3 min read
Save

Testosterone treatment boosts hemoglobin levels for older men with anemia

Testosterone treatment boosts hemoglobin levels for older men with anemia

Testosterone therapy increases hemoglobin levels for older men with anemia and is linked to a lower likelihood for developing anemia for men without the condition, according to study data.

News
November 11, 2023
3 min read
Save

No difference between liberal, restrictive transfusion strategies in acute MI, anemia

No difference between liberal, restrictive transfusion strategies in acute MI, anemia

PHILADELPHIA — In patients with acute MI and anemia, there was no difference between liberal and restrictive transfusion strategies for the composite outcome of death and MI at 30 days, according to results of the MINT trial.

News
November 08, 2023
2 min read
Save

Survey shows limited uptake with new anemia drugs

Survey shows limited uptake with new anemia drugs

PHILADELPHIA — Results of a survey conducted in the U.S. and abroad showed that most nephrologists remain wary about prescribing hypoxia-inducible factor-prolyl hydroxylase inhibitors, according to a poster presentation at ASN Kidney Week.

News
November 04, 2023
1 min read
Save

Lower rates of access thrombosis for patients with CKD who receive daprodustat vs. EPO

Lower rates of access thrombosis for patients with CKD who receive daprodustat vs. EPO

PHILADELPHIA — Patients with chronic kidney disease on dialysis who received daprodustat had fewer vascular access thrombosis events compared with patients who had erythropoiesis-stimulating agents, according to data presented here.

News
October 26, 2023
1 min read
Save

Akebia gets FDA review date of March 2024 for anemia drug vadadustat

Akebia gets FDA review date of March 2024 for anemia drug vadadustat

The FDA has set a user fee goal date of March 27, 2024, for review of the oral hypoxia-inducible factor prolyl hydroxylase inhibitor vadadustat for the treatment of anemia in adults on dialysis.

News
October 24, 2023
2 min read
Save

Updated COVID-19 vaccines receive mixed support among health care professionals online

Updated COVID-19 vaccines receive mixed support among health care professionals online

An analysis of online conversations among health care professionals on social media during September revealed mixed reactions toward newly updated messenger RNA COVID-19 vaccines.

News
October 05, 2023
2 min watch
Save

VIDEO: Understanding the role of inflammation in anemia

VIDEO: Understanding the role of inflammation in anemia

Healio spoke with Jay B. Wish, MD, about managing anemia in patients on dialysis.

View more